Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 15, 2020
The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple SclerosisMichael Zhong, Anneke van der Walt, Maria Pia Campagna, et al.
Autoimmunity Reviews|June 23, 2023
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomesMaria Pia Campagna, Jeannette Lechner-Scott, Vicki E Maltby, et al.
Clinical Epigenetics|December 5, 2021
Epigenome-wide association studies: current knowledge, strategies and recommendationsMaria Pia Campagna, Alexandre Xavier, Jeannette Lechner-Scott, et al.
Clinical Epigenetics|December 30, 2022
Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severityMaria Pia Campagna, Alexandre Xavier, Rodney A Lea, et al.
Frontiers in Immunology|June 16, 2023
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosisAlexandre Xavier, Maria Pia Campagna, Vicki E Maltby, et al.
Clinical Epigenetics|February 11, 2023
Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosisMaria Pia Campagna, Alexandre Xavier, Jim Stankovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 21, 2024
No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registryMaria Pia Campagna, Eva Kubala Havrdova, Dana Horakova, et al.
International Journal of MS Care|June 28, 2021
Patient Preferences for Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic DisordersLouise Rath, Maria Pia Campagna, Jim Stankovich, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2024
The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trialWei Zhen Yeh, Melissa Gresle, Rodney Lea, et al.
Neurology|August 4, 2023
Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple SclerosisVicki Maltby, Alexandre Xavier, Ewoud Ewing, et al.
Pageof 2